• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

Innovate IndianaNews and information on how IU is driving innovation, entrepreneurship and economic development

Cell therapy company licenses IU School of Medicine tech that creates blood vessels

Posted on April 4, 2016 by Steve Martin

Indiana University Research and Technology Corp., which protects intellectual property developed in the Indiana University campus system, has licensed technology that creates human blood vessels to Cellular Dynamics International, a Fujifilm company based in Madison, Wisconsin.

Mervin C. Yoder
Mervin C. Yoder

The technology was developed by Dr. Mervin C. Yoder, the Richard and Pauline Klinger Professor of Pediatrics and professor of biochemistry and molecular biology at the Indiana University School of Medicine. He said a condition called peripheral arterial disease, caused by damaged blood vessels, diminishes blood flow to a person’s lower extremities, with potentially serious consequences.

“About eight to 12 million Americans and 27 million people in Europe and North America are affected by peripheral arterial disease,” Yoder said. “Treatment costs in the United States alone are greater than $4.5 billion. Because their blood vessels have been damaged, patients may develop ulcers or gangrene. Twenty-eight percent require foot or limb amputation. The technology licensed to Cellular Dynamics International may be useful to restore the delivery of blood and avoid amputation.”

The technology creates cells that are injected in a gel material directly into a limb to encourage the regeneration of small blood vessels. Users also can use 3-D bioprinting to make the cells necessary to create artificial blood vessels that can be transplanted into the limb.

Tak Okada, chief technology officer at Cellular Dynamics International, said the company is pleased to license this novel method to develop the technology for therapeutic use, with potential customers in the pharmaceutical and biopharmaceutical sectors.

“We believe that Dr. Yoder’s novel technology for the creation of blood vessels has therapeutic potential for the treatment of PAD, a disease for which there are limited treatment options today,” he said. “A large number of cells are necessary for any therapeutic application, and we chose to license this technology not only because it produces the quality of cells necessary for therapeutic use, but also because it enables the quantity by large volume production.”

For information about other IU technologies available for licensing, visit the IURTC website, email iurtc@indiana.edu or call 317-274-5905.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Filed under: UncategorizedTagged IU School of Medicine, licensing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Innovate Indiana Button

Search Innovate Indiana

About Innovate Indiana

Join us as we highlight how IU innovation is accelerating economic growth in Indiana and beyond and creating a culture of entrepreneurship across the Hoosier state.

Innovate Indiana is maintained by the Indiana University Office of the Vice President for University Relations.

Subscribe to the Innovate Indiana Blog

Sign up to receive regular updates from Innovate Indiana Blog

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent Posts

  • IU, NSWC Crane partner on research initiative to help secure Navy's AI, machine learning systems February 1, 2023
  • IU’s, state’s participation in first-ever NBA games in India helps alumni investors score, spotlights potential economic benefits of engagement with country’s growing venture capital landscape January 31, 2023
  • IU researchers seek to commercialize AI tool to identify undiagnosed cases of early-stage Alzheimer’s disease and related dementia January 24, 2023
  • IU researchers win Translational Research grant for plastic neutron shield material technology January 20, 2023
  • IU-affiliated startup wins the Regional Pre-Seed Award from Elevate Nexus Southern Region Pitch Competition January 17, 2023

Categories

Bookmarks

  • Innovate Indiana website
  • IU Center on Representative Government
  • IU Impact
  • IU Innovation and Commercialization Office
  • IU Office of the Vice President for Research
  • IU Office of the Vice President for University Relations
  • IU Ventures

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.